Integrated Filing — IndAS



General information about company
Scrip Code 544339
NSE Symbol LAXMIDENTL
MSEI Symbol NOTLISTED
ISIN INE0WO601020
Name of company Laxmi Dental Limited
Type of company Main Board
Class of security Equity
Date of start of financial year 01-Apr-2024
Date of end of financial year 31-Mar-2025
Date of board meeting when results were approved 26-May-2025
Date on which prior intimation of the meeting for considering financial results was informed to the exchange 21-May-2025
Description of presentation currency INR (in Actuals)
Reporting Type Quarterly
Reporting Quarter Fourth quarter
Nature of report standalone or consolidated Standalone
Whether results are audited or unaudited for the quarter ended Audited
Whether results are audited or unaudited for the Year to date for current period ended/year ended Audited
Segment Reporting Single segment
Description of single segment Integrated Dental Products
Start date and time of board meeting 26-May-2025   17:00:00
End date and time of board meeting 26-May-2025   23:55:00
Whether cash flow statement is applicable on company Yes
Type of cash flow statement Cash Flow Indirect
Declaration of unmodified opinion or statement on impact of audit qualification Declaration of unmodified opinion
Whether the company has any related party? Yes
Whether the company has entered into any Related Party transaction during the selected half year for which it wants to submit disclosure? Yes
(I) We declare that the acceptance of fixed deposits by the bans/Non-Banking Finance Company are at the terms uniformly applicable/offered to all shareholders/public NA
(II) We declare that the scheduled commercial bank, as per RBI circular RBI/DBR/2015-16/19 dated March 03, 2016, has allowed additional interest of one per cent per annum, over and above the rate of interest mentioned in the schedule of interest rates on savings or a term deposits of banks staff and their exclusive associations as well as on deposits of Chairman, Chairman & Managing Director, Executive Director or such other Executives appointed for a fixed tenure. NA
Whether the company is a high value debt listed entity according to regulation 15 (1A)? No
(a) If answer to above question is Yes, whether complying with proviso to regulation 23 (9), i.e., submitting RPT disclosures on the day of results publication?
(b) If answer to above question is No, please explain the reason for not complying.
Whether the updated Related Party Transactions (RPT) Policy (in compliance with Reg. 23 of SEBI LODR) has been uploaded on the website of the Company? Yes
Latest Date on which RPT policy is updated 2025-02-13
Indicate Company website link for updated RPT policy of the Company https://www.laxmidentallimited.com/corporate_governance/policies
Whether statement on deviation or variation for proceeds of public issue, rights issue, preferential issue, qualified institutions placement etc. is applicable to the company for the current quarter? Yes
No. of times funds raised during the quarter 1
Whether the disclosure for the Default on Loans and Debt Securities is applicable to the entity? Yes



Financial Results Ind-AS
Particulars 3 months/ 6 months ended (dd-mm-yyyy) Year to date figures for current period ended (dd-mm-yyyy)
A Date of start of reporting period 01-Jan-2025 01-Apr-2024
B Date of end of reporting period 31-Mar-2025 31-Mar-2025
C Whether results are audited or unaudited Audited Audited
D Nature of report standalone or consolidated Standalone Standalone
Part I Blue color marked fields are non-mandatory. For Consolidated Results, if the company has no figures for 3 months / 6 months ended, in such case zero shall be inserted in the said column.
1 Income
Revenue from operations 426850000 1712440000
Other income 21780000 46200000
Total income 448630000 1758640000
2 Expenses
(a) Cost of materials consumed 55000000 425510000
(b) Purchases of stock-in-trade 57470000 112920000
(c) Changes in inventories of finished goods, work-in-progress and stock-in-trade -12590000 7360000
(d) Employee benefit expense 178340000 610610000
(e) Finance costs 7020000 36500000
(f) Depreciation, depletion and amortisation expense 28290000 98170000
(f) Other Expenses
1 Other Expenses 75170000 294300000
Total other expenses 75170000 294300000
Total expenses 388700000 1585370000
3 Total profit before exceptional items and tax 59930000 173270000
4 Exceptional items 4100000 70270000
5 Total profit before tax 64030000 243540000
6 Tax expense
7 Current tax 12460000 12460000
8 Deferred tax 17240000 45010000
9 Total tax expenses 29700000 57470000
10 Net movement in regulatory deferral account balances related to profit or loss and the related deferred tax movement 0 0
11 Net Profit Loss for the period from continuing operations 34330000 186070000
12 Profit (loss) from discontinued operations before tax 0 0
13 Tax expense of discontinued operations 0 0
14 Net profit (loss) from discontinued operation after tax 0 0
15 Share of profit (loss) of associates and joint ventures accounted for using equity method 7420000 71680000
16 Total profit (loss) for period 41750000 257750000
17 Other comprehensive income net of taxes -4360000 -5480000
18 Total Comprehensive Income for the period 37390000 252270000
19 Total profit or loss, attributable to
Profit or loss, attributable to owners of parent
Total profit or loss, attributable to non-controlling interests
20 Total Comprehensive income for the period attributable to
Comprehensive income for the period attributable to owners of parent
Total comprehensive income for the period attributable to owners of parent non-controlling interests
21 Details of equity share capital
Paid-up equity share capital 109920000 109920000
Face value of equity share capital 2 2
27 Details of debt securities
22 Reserves excluding revaluation reserve 2117450000
23 Earnings per share
i Earnings per equity share for continuing operations
Basic earnings (loss) per share from continuing operations 0.77 4.92
Diluted earnings (loss) per share from continuing operations 0.76 4.91
ii Earnings per equity share for discontinued operations
Basic earnings (loss) per share from discontinued operations 0 0
Diluted earnings (loss) per share from discontinued operations 0 0
ii Earnings per equity share
Basic earnings (loss) per share from continuing and discontinued operations 0.77 4.92
Diluted earnings (loss) per share from continuing and discontinued operations 0.76 4.91
24 Debt equity ratio
25 Debt service coverage ratio
26 Interest service coverage ratio
27 Disclosure of notes on financial results Textual Information(1)



Disclosure of notes on financial results
Textual Information(1) Note to the Standalone Financial Results: n1 The audited standalone financial results for the year ended 31 March 2025 has been prepared on the basis of the standalone annual financial statements in accordance with the Indian Accounting Standards (Ind AS) as notified under the Companies (Indian Accounting Standards) Rules 2015 (as amended) specified under section 133 of the Companies Act, 2013 and in compliance with Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 ('the Regulation'), as amended were reviewed and recommended by the Audit Committee and approved by the Board of Directors at their respective meeting held on 26 May 2025. The Statutory Auditors of the Company have expressed an unmodified opinion on the audited standalone financial results for the year ended 31 March 2025. n n2 The figures of the quarter ended 31 March 2025 are the balancing figures between the audited figures in respect of full financial year and the unaudited published year-to-date figures upto 31 December 2024 which were subject to limited review. n n3 The figures of the quarter ended 31 March 2024 are the balancing figures between the audited figures in respect of full financial year (General purpose standalone financial statements of the Company) and the year-to-date figures upto 31 December 2023, based on the information compiled by the management in accordance with IND AS and have not been subjected to review or audit by the statutory auditor or by any other auditor. n n4 As permitted by paragraph 4 of Indian Accounting Standard (Ind AS) 108 “Operating Segments”, notified under Section 133 of the Companies Act, 2013, read together with the relevant rules issued thereunder, if a single financial report contains both consolidated financial statements and the separate financial statements of the parent, segment information need to be presented only on the basis of the consolidated financial statements. Thus, disclosure required by Regulation 33 of the SEBI (Listing Obligations & Disclosure Requirements) Regulations, 2015 on segment wise revenue results and capital employed are given in consolidated financial results. n n5 During the year ended 31 March 2025, the Company has converted the 0.0001% Compulsorily Convertible Preference Shares (CCPS) aggregating to n290,597 preference shares of par value of Rs. 400 each to 23,922,450 Equity Shares of Rs. 2 each. n n6 During the year, the Board of Directors and Shareholders of the Company has approved the Employee Stock Option Plan 2024 (“ESOP 2024”) for the employees of the Company and its subsidiary companies comprising of equity shares of the Company, not exceeding 5,00,000 equity shares of face value of Rs. 2/- each. The company has granted 351, 672 equity shares of face value of Rs. 2/- each on 14 December 2024 to its eligible employees. n n7 On 7 May 2024, the Company sold one of its Investment properties at the sale consideration of Rs. 101 million. The book value of the aforesaid Property as on the date of sale was Rs. 7.10 million. The Company accounted for difference between the sale consideration and book value as gain on sale of Investment property amounting to Rs. 70.27 million (net of tax Rs. 23.64 million) as an exceptional gain. Subsequent to the quarter and six month period ended 30 September 2024, the Company has opted to avail benefit of section 115BAA and the corresponding revision of net tax effect has been considered in the exception items. n n8 During the year ended 31 March 2025, the Company split its 309,060 equity shares of face value of Rs.10 each to 1,545,300 Equity Shares of face value of Rs.2 each. Further, on approval of the Board of Directors and Shareholders, the company issued 26,270,100 bonus shares (17:1) face value of Rs. 2 each, by capitalizing the free reserves. Basic and Diluted EPS disclosed after considering effect of bonus and split equity shares issued. n n9 During the quarter and year ended 31 March 2025, the Company has completed an Initial Public Offer of 16,309,766 equity shares of face value of Rs. 2/- each comprising of (i) fresh issue of 3,224,299 equity shares at an issue price of Rs. 428 per equity share aggregating to Rs. 1,380 million, and (ii) an offer for sale of 13,085,467 equity shares at an issue price of Rs. 428 per equity share aggregating to Rs. 5,600.58 million and listed on both Bombay Stock Exchange Limited (BSE) and National Stock Exchange (NSE) on 20 January 2025. The Company has received gross proceeds from fresh issue of Rs. 1,380.00 million nagainst which Company has incurred an estimated issue related expenses (net off tax) of Rs. 92.29 million. n nObjects of the issue(as per Utilised upto 31 March 2025 Unutilised as on 31 March n nParticulars n noffer document) n n2025 n n n nRepayment/prepayment, in full or in part, of certain outstanding borrowings availed by our company nInvestment in certain Subsidiaries for the repayment/ nprepayment, in full or in part, of certain outstanding borrowings n nFunding of capital expenditure requirements for purchase of new machinery for our Company nInvestments in our Subsidiary, Bizdent Devices Private Limited, for the capital expenditure requirements for the purchase of new machinery nGeneral Corporate purposes n n229.84 229.84 - n n46.00 - 46.00 n n n435.07 7.43 427.64 n n250.04 - 250.04 n n n320.75 94.10 226.65 n nTotal utilisation of funds 1,281.70 331.37 950.33 n nOut of the net proceeds which were unutilised as at 31 March 2025, Rs 950.33 million are temporarily invested in fixed deposits. n n10 Previous year/period figures have been regrouped/ reclassified whenever necessary to confirm to current year's classification. n n11 The financial results of the Company are available on the Company's website (www.laxmidentallimited.com) and stock exchanges websites, BSE (www.bseindia.com) and NSE (www.nseindia.com), where the shares of the Company are listed. n



Remarks
Debt equity ratio
Debt service coverage ratio
Interest service coverage ratio


Statement of Asset and Liabilities
Particulars Year ended (dd-mm-yyyy)
Date of start of reporting period 01-Apr-2024
Date of end of reporting period 31-Mar-2025
Whether results are audited or unaudited Audited
Nature of report standalone or consolidated Standalone
Assets
1 Non-current assets
Property, plant and equipment 332920000
Capital work-in-progress
Investment property 0
Goodwill 0
Other intangible assets 63870000
Intangible assets under development 2150000
Biological assets other than bearer plants
Investments accounted for using equity method
Non-current financial assets
Non-current investments 170290000
Trade receivables, non-current
Loans, non-current 0
Other non-current financial assets 258160000
Total non-current financial assets 428450000
Deferred tax assets (net) 58090000
Other non-current assets 32390000
Total non-current assets 917870000
2 Current assets
Inventories 166720000
Current financial asset
Current investments 0
Trade receivables, current 317080000
Cash and cash equivalents 884840000
Bank balance other than cash and cash equivalents 185420000
Loans, current 6320000
Other current financial assets 144930000
Total current financial assets 1538590000
Current tax assets (net)
Other current assets 106670000
Total current assets 1811980000
3 Non-current assets classified as held for sale
4 Regulatory deferral account debit balances and related deferred tax Assets
Total assets 2729850000
Equity and liabilities
1 Equity
Equity attributable to owners of parent
Equity share capital 109920000
Other equity 2117450000
Total equity attributable to owners of parent 2227370000
Non controlling interest
Total equity 2227370000
2 Liabilities
Non-current liabilities
Non-current financial liabilities
Borrowings, non-current 0
Trade payables, non-current
(A) Total outstanding dues of micro enterprises and small enterprises
(B) Total outstanding dues of creditors other than micro enterprises and small enterprises
Total Trade payable
Other non-current financial liabilities 5400000
Total non-current financial liabilities 5400000
Provisions, non-current 28670000
Deferred tax liabilities (net)
Deferred government grants, Non-current
Other non-current liabilities 35940000
Total non-current liabilities 70010000
Current liabilities
Current financial liabilities
Borrowings, current 0
Trade payables, current
(A) Total outstanding dues of micro enterprises and small enterprises 14460000
(B) Total outstanding dues of creditors other than micro enterprises and small enterprises 278480000
Total Trade payable 292940000
Other current financial liabilities 52170000
Total current financial liabilities 345110000
Other current liabilities 68000000
Provisions, current 9450000
Current tax liabilities (Net) 9910000
Deferred government grants, Current
Total current liabilities 432470000
3 Liabilities directly associated with assets in disposal group classified as held for sale
4 Regulatory deferral account credit balances and related deferred tax liability
Total liabilities 502480000
Total equity and liabilites 2729850000
Disclosure of notes on assets and liabilities



Format for Reporting Segmenet wise Revenue, Results and Capital Employed along with the company results
Particulars 3 months/ 6 month ended (dd-mm-yyyy) Year to date figures for current period ended (dd-mm-yyyy)
Date of start of reporting period 01-Jan-2025 01-Apr-2024
Date of end of reporting period 31-Mar-2025 31-Mar-2025
Whether accounts are audited or unaudited Audited Audited
Nature of report standalone or consolidated Standalone Standalone
1 Segment Revenue (Income)
(net sale/income from each segment should be disclosed)
Total Segment Revenue
Less: Inter segment revenue
Revenue from operations
2 Segment Result
Profit (+) / Loss (-) before tax and interest from each segment
Total Profit before tax
i. Finance cost
ii. Other Unallocable Expenditure net off Unallocable income
Profit before tax
3 (Segment Asset - Segment Liabilities)
Segment Asset
Total Segment Asset
Un-allocable Assets null null
Net Segment Asset null null
4 Segment Liabilities
Segment Liabilities
Total Segment Liabilities
Un-allocable Liabilities null null
Net Segment Liabilities null null
Disclosure of notes on segments



Other Comprehensive Income
Particulars 3 months/ 6 months ended (dd-mm-yyyy) Year to date figures for current period ended (dd-mm-yyyy)
A Date of start of reporting period 01-Jan-2025 01-Apr-2024
B Date of end of reporting period 31-Mar-2025 31-Mar-2025
C Whether results are audited or unaudited Audited Audited
D Nature of report standalone or consolidated Standalone Standalone
Other comprehensive income [Abstract]
1 Amount of items that will not be reclassified to profit and loss
1 Remeasurement of net defined benefit liabilities/Assets -5740000 -7320000
2 Income Tax effect on above 1380000 1840000
Total Amount of items that will not be reclassified to profit and loss -4360000 -5480000
2 Income tax relating to items that will not be reclassified to profit or loss 0 0
3 Amount of items that will be reclassified to profit and loss
Total Amount of items that will be reclassified to profit and loss
4 Income tax relating to items that will be reclassified to profit or loss 0 0
5 Total Other comprehensive income -4360000 -5480000



Cash flow statement, indirect
Particulars Year ended (dd-mm-yyyy)
A Date of start of reporting period 01-Apr-2024
B Date of end of reporting period 31-Mar-2025
C Whether results are audited or unaudited Audited
D Nature of report standalone or consolidated Standalone
Part I Blue color marked fields are non-mandatory.
Statement of cash flows
Cash flows from used in operating activities
Profit before tax 243540000
Adjustments for reconcile profit (loss)
Adjustments for finance costs 36500000
Adjustments for decrease (increase) in inventories 60400000
Adjustments for decrease (increase) in trade receivables, current 35060000
Adjustments for decrease (increase) in trade receivables, non-current 0
Adjustments for decrease (increase) in other current assets -31620000
Adjustments for decrease (increase) in other non-current assets 0
Adjustments for other financial assets, non-current -55210000
Adjustments for other financial assets, current 0
Adjustments for other bank balances 0
Adjustments for increase (decrease) in trade payables, current 131040000
Adjustments for increase (decrease) in trade payables, non-current 0
Adjustments for increase (decrease) in other current liabilities -27830000
Adjustments for increase (decrease) in other non-current liabilities 0
Adjustments for depreciation and amortisation expense 98170000
Adjustments for impairment loss reversal of impairment loss recognised in profit or loss 0
Adjustments for provisions, current -1240000
Adjustments for provisions, non-current 0
Adjustments for other financial liabilities, current 0
Adjustments for other financial liabilities, non-current 8310000
Adjustments for unrealised foreign exchange losses gains -15710000
Adjustments for dividend income 0
Adjustments for interest income 13270000
Adjustments for share-based payments 11630000
Adjustments for fair value losses (gains) -70540000
Adjustments for undistributed profits of associates 0
Other adjustments for which cash effects are investing or financing cash flow 0
Other adjustments to reconcile profit (loss) 0
Other adjustments for non-cash items 2000000
Share of profit and loss from partnership firm or association of persons or limited liability partnerships 71680000
Total adjustments for reconcile profit (loss) 239370000
Net cash flows from (used in) operations 482910000
Dividends received 0
Interest paid 0
Interest received 0
Income taxes paid (refund) 12310000
Other inflows (outflows) of cash 0
Net cash flows from (used in) operating activities 470600000
Cash flows from used in investing activities
Cash flows from losing control of subsidiaries or other businesses 0
Cash flows used in obtaining control of subsidiaries or other businesses 15010000
Other cash receipts from sales of equity or debt instruments of other entities 0
Other cash payments to acquire equity or debt instruments of other entities 0
Other cash receipts from sales of interests in joint ventures 0
Other cash payments to acquire interests in joint ventures 0
Cash receipts from share of profits of partnership firm or association of persons or limited liability partnerships 0
Cash payment for investment in partnership firm or association of persons or limited liability partnerships 0
Proceeds from sales of property, plant and equipment 0
Purchase of property, plant and equipment 123370000
Proceeds from sales of investment property 76350000
Purchase of investment property 0
Proceeds from sales of intangible assets 0
Purchase of intangible assets 0
Proceeds from sales of intangible assets under development 0
Purchase of intangible assets under development 8650000
Proceeds from sales of goodwill 0
Purchase of goodwill 0
Proceeds from biological assets other than bearer plants 0
Purchase of biological assets other than bearer plants 0
Proceeds from government grants 0
Proceeds from sales of other long-term assets 0
Purchase of other long-term assets 0
Cash advances and loans made to other parties 4690000
Cash receipts from repayment of advances and loans made to other parties 0
Cash payments for future contracts, forward contracts, option contracts and swap contracts 0
Cash receipts from future contracts, forward contracts, option contracts and swap contracts 0
Dividends received 0
Interest received 12550000
Income taxes paid (refund) 0
Other inflows (outflows) of cash -423930000
Net cash flows from (used in) investing activities -486750000
Cash flows from used in financing activities
Proceeds from changes in ownership interests in subsidiaries 0
Payments from changes in ownership interests in subsidiaries 0
Proceeds from issuing shares 1380000000
Proceeds from issuing other equity instruments 0
Payments to acquire or redeem entity's shares 0
Payments of other equity instruments 0
Proceeds from exercise of stock options 0
Proceeds from issuing debentures notes bonds etc 0
Proceeds from borrowings 203850000
Repayments of borrowings 446670000
Payments of lease liabilities 25990000
Dividends paid 0
Interest paid 36500000
Income taxes paid (refund) 0
Other inflows (outflows) of cash -38670000
Net cash flows from (used in) financing activities 1036020000
Net increase (decrease) in cash and cash equivalents before effect of exchange rate changes 1019870000
Effect of exchange rate changes on cash and cash equivalents
Effect of exchange rate changes on cash and cash equivalents 0
Net increase (decrease) in cash and cash equivalents 1019870000
Cash and cash equivalents cash flow statement at beginning of period -135020000
Cash and cash equivalents cash flow statement at end of period 884850000





Details of Impact of Audit Qualification
Whether results are audited or unaudited Audited
Declaration of unmodified opinion or statement on impact of audit qualification Declaration of unmodified opinion
Auditor's opinion
Declaration pursuant to Regulation 33 (3) (d) of SEBI (LODR) Regulation, 2015: The company declares that its Statutory Auditor/s have issued an Audit Report with unmodified opinion for the period on Standalone results Yes
Sr No. Audit firm's name Whether the firm holds a valid peer review certificate issued by Peer Review Board of ICAI Certificate valid upto
1 M S K A & Associates Yes 31-Jul-2027


Statement on Deviation or Variation for proceeds of Public Issue, Rights Issue, Preferential Issue, Qualified Institutions Placement Etc. (1)
Mode of Fund Raising Public Issues
Description of mode of fund raising (Applicable in case of others is selected)
Date of Raising Funds 16-Jan-2025
Amount Raised 6980580000
Report filed for Quarter ended 31-Mar-2025
Monitoring Agency Applicable
Monitoring Agency Name, if applicable ICRA Limited
Is there a Deviation / Variation in use of funds raised No
If yes, whether the same is pursuant to change in terms of a contract or objects, which was approved by the shareholders
If Yes, Date of shareholder Approval
Explanation for the Deviation / Variation
Comments of the Audit Committee after review
Comments of the auditors, if any
Sr. Original Object Modified Object, if any Original Allocation Modified allocation, if any Funds Utilised Amount of Deviation/Variation for the quarter according to applicable object Remarks if any
1 Repayment/prepayment, in full or in part, of certain outstanding borrowings availed by our Company NA 229840000 0 229840000 0
2 Investment in certain Subsidiaries for the repayment/prepayment, in full or in part, of certain outstanding borrowings. NA 46000000 0 0 0
3 Funding the capital expenditure requirements for purchase of new machinery for our Company. NA 435070000 0 7430000 0
4 Investment in our Subsidiary, Bizdent Devices Private Limited, for the capital expenditure requirements for the purchase of new machinery. NA 250040000 0 0 0
5 General corporate purposes. NA 320750000 0 94100000 0


Signatory Details
Name of signatory Sameer Kamlesh Merchant
Designation of person Managing Director
Place Mumbai
Date 26-May-2025




Format for Disclosure of Related Party Transactions (applicable only for half-yearly filings i.e., 2nd and 4th quarter)
Sr No. Additional disclosure of related party transactions - applicable only in case the related party transaction relates to loans, inter-corporate deposits, advances or investments made or given by the listed entity/subsidiary. These details need to be disclosed only once, during the reporting period when such transaction was undertaken.
Details of the party (listed entity/subsidiary) entering into the transaction Details of the counterparty Type of related party transaction Details of other related party transaction Value of the related party transaction as approved by the audit committee Remarks on approval by audit committee Value of the related party transaction ratified by the audit committee Date of Audit Committee Meeting where the ratification was approved Value of transaction during the reporting period In case monies are due to either party as a result of the transaction In case any financial indebtedness is incurred to make or give loans, inter-corporate deposits, advances or investments Details of the loans, inter-corporate deposits, advances or investments Notes
Name PAN Name PAN Relationship of the counterparty with the listed entity or its subsidiary Opening balance Closing balance Nature of indebtedness (loan/ issuance of debt/ any other etc.) Details of other indebtedness Cost Tenure Nature (loan/ advance/ intercorporate deposit/ investment ) Interest Rate (%) Tenure Secured/ unsecured Purpose for which the funds will be utilised by the ultimate recipient of funds (endusage)
1 Laxmi Dental Limited (Formerly known as Laxmi Dental Export Private Limited) Mr. Rajesh Khakhar Whole time Director & Chairman Remuneration 8400000 Approved 8400000 380000 700000
2 Laxmi Dental Limited (Formerly known as Laxmi Dental Export Private Limited) Mr. Rajesh Khakhar Whole time Director & Chairman Any other transaction Rent Paid 690000 Approved 690000 0 0
3 Laxmi Dental Limited (Formerly known as Laxmi Dental Export Private Limited) Mr. Rajesh Khakhar Whole time Director & Chairman Interest paid 720000 Approved 720000 0 0
4 Laxmi Dental Limited (Formerly known as Laxmi Dental Export Private Limited) Mr. Rajesh Khakhar Whole time Director & Chairman Loan 26560000 Approved 26560000 26560000 0 Loan 0.105 Repayable on Demand Unsecured Working Capital Textual Information(1)
5 Laxmi Dental Limited (Formerly known as Laxmi Dental Export Private Limited) Mr. Amrish Desai Director (upto 27-Apr-2024) Interest paid 140000 Approved 140000 0 0
6 Laxmi Dental Limited (Formerly known as Laxmi Dental Export Private Limited) Mr. Amrish Desai Director (upto 27-Apr-2024) Loan 1640000 Approved 1640000 1640000 0 Loan 0.105 Repayable on Demand Unsecured Working Capital Textual Information(2)
7 Laxmi Dental Limited (Formerly known as Laxmi Dental Export Private Limited) Mr. Hasmukh Khakhar Director (upto 20-Apr-2024) Interest paid 510000 Approved 510000 0 0
8 Laxmi Dental Limited (Formerly known as Laxmi Dental Export Private Limited) Mr. Hasmukh Khakhar Director (upto 20-Apr-2024) Loan 6000000 Approved 6000000 0 0
9 Laxmi Dental Limited (Formerly known as Laxmi Dental Export Private Limited) Mr. Sameer Merchant CEO and Managing Director Remuneration 8400000 Approved 8400000 380000 700000
10 Laxmi Dental Limited (Formerly known as Laxmi Dental Export Private Limited) Mr. Sameer Merchant CEO and Managing Director Interest paid 80000 Approved 80000 0 0
11 Laxmi Dental Limited (Formerly known as Laxmi Dental Export Private Limited) Mr. Sameer Merchant CEO and Managing Director Loan 11000000 Approved 11000000 11000000 0 Loan 0.105 Repayable on Demand Unsecured Working Capital Textual Information(3)
12 Laxmi Dental Limited (Formerly known as Laxmi Dental Export Private Limited) Mr. Dharmesh Dattani Chief Finance Officer Remuneration 5850000 Approved 5850000 330000 450000
13 Laxmi Dental Limited (Formerly known as Laxmi Dental Export Private Limited) Mr. Manan Khakhar Relative of direcotrs And KMP Remuneration 3540000 Approved 3540000 150000 300000
14 Laxmi Dental Limited (Formerly known as Laxmi Dental Export Private Limited) Mr. Parth Khakhar Relative of direcotrs And KMP Remuneration 8890000 Approved 8890000 0 750000
15 Laxmi Dental Limited (Formerly known as Laxmi Dental Export Private Limited) Mr. Shubh Sanjay Khakhar Relative of direcotrs And KMP Remuneration 2500000 Approved 2500000 50000 210000
16 Laxmi Dental Limited (Formerly known as Laxmi Dental Export Private Limited) Bizdent Devices Pvt. Ltd. Subsidiary Purchase of goods or services 44810000 Approved 44810000 640000 10000
17 Laxmi Dental Limited (Formerly known as Laxmi Dental Export Private Limited) Bizdent Devices Pvt. Ltd. Subsidiary Sale of goods or services 82700000 Approved 82700000 20990000 12290000
18 Laxmi Dental Limited (Formerly known as Laxmi Dental Export Private Limited) Bizdent Devices Pvt. Ltd. Subsidiary Any other transaction Other Expenses 9080000 Approved 9080000 0 0
19 Laxmi Dental Limited (Formerly known as Laxmi Dental Export Private Limited) Bizdent Devices Pvt. Ltd. Subsidiary Any other transaction Interest Paid 3960000 Approved 3960000 0 0
20 Laxmi Dental Limited (Formerly known as Laxmi Dental Export Private Limited) Bizdent Devices Pvt. Ltd. Subsidiary Loan 90000000 Approved 90000000 0 0
21 Laxmi Dental Limited (Formerly known as Laxmi Dental Export Private Limited) Bizdent Devices Pvt. Ltd. Subsidiary Loan 90000000 Approved 90000000 0 0
22 Laxmi Dental Limited (Formerly known as Laxmi Dental Export Private Limited) Bizdent Devices Pvt. Ltd. Subsidiary Advance 1780000 Approved 1780000 0 0
23 Laxmi Dental Limited (Formerly known as Laxmi Dental Export Private Limited) Bizdent Devices Pvt. Ltd. Subsidiary Investment 35100000 Approved 35100000 0 0
24 Laxmi Dental Limited (Formerly known as Laxmi Dental Export Private Limited) Kids E Dental LLP Jointly controlled Entity Purchase of goods or services 120000 Approved 120000 0 100000
25 Laxmi Dental Limited (Formerly known as Laxmi Dental Export Private Limited) Kids E Dental LLP Jointly controlled Entity Sale of goods or services 15570000 Approved 15570000 0 100000
26 Laxmi Dental Limited (Formerly known as Laxmi Dental Export Private Limited) Kids E Dental LLP Jointly controlled Entity Any other transaction Other Income 40000 Approved 40000 0 100000
27 Laxmi Dental Limited (Formerly known as Laxmi Dental Export Private Limited) Kids E Dental LLP Jointly controlled Entity Any other transaction Rent Income 60000 Approved 60000 0 100000
28 Laxmi Dental Limited (Formerly known as Laxmi Dental Export Private Limited) Kids E Dental LLP Jointly controlled Entity Any other transaction Other Expenses 1760000 Approved 1760000 0 100000
29 Laxmi Dental Limited (Formerly known as Laxmi Dental Export Private Limited) Kids E Dental LLP Jointly controlled Entity Any other transaction Share in Profit of Joint Vanture 71680000 Approved 71680000 59290000 102230000
30 Laxmi Dental Limited (Formerly known as Laxmi Dental Export Private Limited) Kids E Dental LLP Jointly controlled Entity Investment 300000 Approved 300000 0 0
31 Laxmi Dental Limited (Formerly known as Laxmi Dental Export Private Limited) Laxmi Dental Lab USA INC Foreign Subsidiary Company Purchase of goods or services 8980000 Approved 8980000 260000 260000
32 Laxmi Dental Limited (Formerly known as Laxmi Dental Export Private Limited) Laxmi Dental Lab USA INC Foreign Subsidiary Company Sale of goods or services 177270000 Approved 177270000 79630000 79630000
33 Laxmi Dental Limited (Formerly known as Laxmi Dental Export Private Limited) Laxmi Dental Lab USA INC Foreign Subsidiary Company Any other transaction Other Income 12180000 Approved 12180000 0 0
34 Laxmi Dental Limited (Formerly known as Laxmi Dental Export Private Limited) Laxmi Dental Lab USA INC Foreign Subsidiary Company Investment 64820000 Approved 64820000 0 0
35 Laxmi Dental Limited (Formerly known as Laxmi Dental Export Private Limited) Rich Smile Design LLP Subsidiary Purchase of goods or services 330000 Approved 330000 0 0
36 Laxmi Dental Limited (Formerly known as Laxmi Dental Export Private Limited) Rich Smile Design LLP Subsidiary Sale of goods or services 3060000 Approved 3060000 740000 200000
37 Laxmi Dental Limited (Formerly known as Laxmi Dental Export Private Limited) Rich Smile Design LLP Subsidiary Any other transaction Other Income 120000 Approved 120000 0 0
38 Laxmi Dental Limited (Formerly known as Laxmi Dental Export Private Limited) Rich Smile Design LLP Subsidiary Investment 70000 Approved 70000 0 0
39 Laxmi Dental Limited (Formerly known as Laxmi Dental Export Private Limited) Siddhileela Properties Entity in which KMP can excersie significant control Sale of fixed assets 101000000 Approved 101000000 0 0
40 Laxmi Dental Limited (Formerly known as Laxmi Dental Export Private Limited) Signature Smiles Dental Clinic Pvt ltd Subsidiary Loan 5000000 Approved 5000000 0 0
41 Laxmi Dental Limited (Formerly known as Laxmi Dental Export Private Limited) Signature Smiles Dental Clinic Pvt ltd Subsidiary Sale of goods or services 6540000 Approved 6540000 330000 620000
42 Laxmi Dental Limited (Formerly known as Laxmi Dental Export Private Limited) Signature Smiles Dental Clinic Pvt ltd Subsidiary Interest received 70000 Approved 70000 0 0
43 Laxmi Dental Limited (Formerly known as Laxmi Dental Export Private Limited) Signature Smiles Dental Clinic Pvt ltd Subsidiary Investment 70000000 Approved 70000000 0 0
44 Laxmi Dental Limited (Formerly known as Laxmi Dental Export Private Limited) Rich Smile Design LLP Subsidiary Investment 320000 Approved 320000 6940000 10990000
45 Laxmi Dental Limited (Formerly known as Laxmi Dental Export Private Limited) Kids E Dental LLP Jointly controlled Entity Any other transaction Withdrawl partners current account 45000000 Approved 45000000 0 0
46 Laxmi Dental Limited (Formerly known as Laxmi Dental Export Private Limited) Kids E Dental LLP Jointly controlled Entity Any other transaction Contribution partners current account 21600000 Approved 21600000 0 0
Total value of transaction during the reporting period 1048240000



Text Block
Textual Information(1) Loan Repaid during Year
Textual Information(2) Loan Repaid during Year
Textual Information(3) Loan Repaid during Year


Format for Disclosing Outstanding Default on Loans and Debt Securities
Sr. No. Particulars Amount Remarks
1. Loans / revolving facilities like cash credit from banks / financial institutions
A Total amount outstanding as on date 0
B Of the total amount outstanding, amount of default as on date 0
2. Unlisted debt securities i.e. NCDs and NCRPS
A Total amount outstanding as on date 0
B Of the total amount outstanding, amount of default as on date 0
3. Total financial indebtedness of the listed entity including short-term and long-term debt 0